Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdate: page now includes a government funding operating status notice and v3.2.0 revision; removes a specific resource on Tenosynovial giant cell tumor and the v3.1.0 tag.SummaryDifference3%
- Check23 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check37 days agoChange DetectedReleased a new v3.0.2 with 2025 dates and an estimated last-update label; older 2024 entries and the Back to Top link were removed.SummaryDifference0.9%
- Check44 days agoChange DetectedThe web page has been updated to include a new publication related to a Phase 3 study of Pexidartinib, which is significant for users interested in the latest research on Tenosynovial Giant Cell Tumor. Additionally, the version number has been updated from v3.0.0 to v3.0.1.SummaryDifference3%
- Check51 days agoChange DetectedThe web page has updated its facility name and location details, while also removing specific location terms and certain medical conditions. Additionally, the version has been revised from v2.16.12 to v3.0.0.SummaryDifference1%
- Check66 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.